149 related articles for article (PubMed ID: 1600855)
1. Glycaemic control and progression of nephropathy in proteinuric NIDDM patients.
Baba T; Tomiyama T; Kodama T; Murabayashi S
Diabetes Res Clin Pract; 1992 May; 16(2):157-9. PubMed ID: 1600855
[No Abstract] [Full Text] [Related]
2. Proteinuria in NIDDM in south India: analysis of predictive factors.
Viswanathan VV; Snehalatha C; Ramachandran A; Viswanathan M
Diabetes Res Clin Pract; 1995 Apr; 28(1):41-6. PubMed ID: 7587911
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients.
Hasslacher C; Bostedt-Kiesel A; Kempe HP; Wahl P
Diabetologia; 1993 Oct; 36(10):1051-6. PubMed ID: 8243854
[TBL] [Abstract][Full Text] [Related]
4. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
[TBL] [Abstract][Full Text] [Related]
5. Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus.
Wainai H; Katsukawa F; Takei I; Maruyama H; Kataoka K; Saruta T
J Diabet Complications; 1991; 5(2-3):160-1. PubMed ID: 1722805
[TBL] [Abstract][Full Text] [Related]
6. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of basement membrane proteins in NIDDM as a prognostic marker for nephropathy.
Okazaki R; Matsuoka K; Atsumi Y; Maruyama K; Matsuki H; Okazaki I
Diabetes Res Clin Pract; 1995 Jan; 27(1):39-49. PubMed ID: 7781493
[TBL] [Abstract][Full Text] [Related]
8. Glycemic status, lipid profile and proteinuria in diabetic nephropathy.
Jha P; Das BK; Shrestha S; Majhi S; Chandra L; Sharma S; Baral N
JNMA J Nepal Med Assoc; 2010; 49(178):143-6. PubMed ID: 21485601
[TBL] [Abstract][Full Text] [Related]
9. Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
Cohen MP; Lautenslager GT; Shearman CW
Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754
[TBL] [Abstract][Full Text] [Related]
10. Urinary type IV collagen as a marker for early diabetic nephropathy.
Kado S; Aoki A; Wada S; Katayama Y; Kugai N; Yoshizawa N; Nagata N
Diabetes Res Clin Pract; 1996 Mar; 31(1-3):103-8. PubMed ID: 8792108
[TBL] [Abstract][Full Text] [Related]
11. Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.
Guo K; Lu J; Kou J; Wu M; Zhang L; Yu H; Zhang M; Bao Y; Chen H; Jia W
BMC Nephrol; 2015 Oct; 16():159. PubMed ID: 26449625
[TBL] [Abstract][Full Text] [Related]
12. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.
Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M
J Diabetes Complications; 1994; 8(1):13-7. PubMed ID: 8167381
[TBL] [Abstract][Full Text] [Related]
13. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
[TBL] [Abstract][Full Text] [Related]
14. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.
Schmitz A; Vaeth M; Mogensen CE
Diabetologia; 1994 Dec; 37(12):1251-8. PubMed ID: 7895955
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for development of proteinuria in NIDDM analyzed by Poisson regression.
Kikuchi M; Matsumoto T; Ohashi Y
J Diabet Complications; 1991; 5(2-3):128-30. PubMed ID: 1770019
[TBL] [Abstract][Full Text] [Related]
16. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.
Chan JC; Cheung CK; Cheung MY; Swaminathan R; Critchley JA; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1013-6. PubMed ID: 7555533
[TBL] [Abstract][Full Text] [Related]
17. Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control.
Alaveras AE; Thomas SM; Sagriotis A; Viberti GC
Nephrol Dial Transplant; 1997; 12 Suppl 2():71-4. PubMed ID: 9269705
[TBL] [Abstract][Full Text] [Related]
18. Glomerular hyperfiltration in NIDDM patients without overt proteinuria.
Silveiro SP; Friedman R; Gross JL
Diabetes Care; 1993 Jan; 16(1):115-9. PubMed ID: 8422764
[TBL] [Abstract][Full Text] [Related]
19. Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.
Joly D; Choukroun G; Combe C; Dussol B; Fauvel JP; Halimi JM; Quéré S; Fiquet B
Diabetes Res Clin Pract; 2015 Apr; 108(1):120-7. PubMed ID: 25726333
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes.
Shigeta Y; Haneda M; Kikkawa R
J Diabet Complications; 1991; 5(2-3):84-6. PubMed ID: 1770061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
